The Rise of Minor Cannabinoids
While CBD remains the dominant cannabinoid in the market, minor cannabinoids are experiencing explosive growth. Brands that diversify beyond CBD are finding new market opportunities, premium pricing, and differentiated product lines.
CBG (Cannabigerol) — Market Leader Among Minors
CBG is the fastest-growing minor cannabinoid by market share. As the “mother cannabinoid” from which all others derive, CBG has captured significant consumer and research interest. Applications include supplements, tinctures, and topicals.
Market outlook: Strong growth trajectory, increasing consumer awareness, supply becoming more available as dedicated CBG hemp cultivars mature.
CBN (Cannabinol) — The Sleep Cannabinoid
CBN has carved a clear niche in the sleep and relaxation market. Nearly every major CBD brand has launched or is developing CBN-infused sleep products. Demand consistently outpaces supply.
Market outlook: High demand, premium pricing, well-defined consumer use case.
CBDA (Cannabidiolic Acid) — The Raw Advantage
CBDA is gaining research attention for potentially superior bioavailability compared to CBD. As the raw, unheated form of CBD, it represents the next frontier in cannabinoid science.
CBGA (Cannabigerolic Acid) — Research Frontier
CBGA is primarily used in research and specialized formulations. As the acidic precursor to CBG, it offers unique properties that are just beginning to be explored commercially.
CBDV (Cannabidivarin) — Rare and Promising
CBDV is one of the rarest commercially available cannabinoids. Its scarcity and unique research profile make it a premium ingredient for brands positioning at the cutting edge of cannabinoid science.
Sourcing Minor Cannabinoids in Bulk
Cannvital manufactures all major minor cannabinoids in our cGMP-certified facility: CBG, CBN, CBDA, CBGA, and CBDV isolates. All products are third-party tested, Halal and Kosher certified. Browse our catalog.